These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11052968)

  • 61. Dexamethasone-induced insulin resistance: kinetic modeling using novel PET radiopharmaceutical 6-deoxy-6-[(18)F]fluoro-D-glucose.
    Su KH; Chandramouli V; Ismail-Beigi F; Muzic RF
    Mol Imaging Biol; 2014 Oct; 16(5):710-20. PubMed ID: 24819311
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals.
    Pendergrass M; Bertoldo A; Bonadonna R; Nucci G; Mandarino L; Cobelli C; Defronzo RA
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E92-100. PubMed ID: 16896161
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regional Variation in Skeletal Muscle and Adipose Tissue FDG Uptake Using PET/CT and Their Relation to BMI.
    Goncalves MD; Green-McKenzie J; Alavi A; Torigian DA
    Acad Radiol; 2017 Oct; 24(10):1288-1294. PubMed ID: 28551398
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
    Minn H; Zasadny KR; Quint LE; Wahl RL
    Radiology; 1995 Jul; 196(1):167-73. PubMed ID: 7784562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glucose uptake of the muscle and adipose tissues in diabetes and obesity disease models: evaluation of insulin and β3-adrenergic receptor agonist effects by
    Ishino S; Sugita T; Kondo Y; Okai M; Tsuchimori K; Watanabe M; Mori I; Hosoya M; Horiguchi T; Kamiguchi H
    Ann Nucl Med; 2017 Jun; 31(5):413-423. PubMed ID: 28401400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of daily voluntary running on in vivo insulin action in rat skeletal muscle and adipose tissue as determined by the microdialysis technique.
    Yang WP; Oshida Y; Wu W; Sato J; Ohsawa I; Sato Y
    Int J Sports Med; 1995 Feb; 16(2):99-104. PubMed ID: 7751085
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Applications of PET in diabetes research.
    Nuutila P
    Horm Metab Res; 1997 Jul; 29(7):337-9. PubMed ID: 9288564
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Measurement of the global lumped constant for 2-deoxy-2-[18F]fluoro-D-glucose in normal human brain using [15O]water and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging. A method with validation based on multiple methodologies.
    Wu HM; Bergsneider M; Glenn TC; Yeh E; Hovda DA; Phelps ME; Huang SC
    Mol Imaging Biol; 2003; 5(1):32-41. PubMed ID: 14499160
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
    Büsing KA; Schönberg SO; Brade J; Wasser K
    Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
    Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
    J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
    J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension.
    Nuutila P; Mäki M; Laine H; Knuuti MJ; Ruotsalainen U; Luotolahti M; Haaparanta M; Solin O; Jula A; Koivisto VA
    J Clin Invest; 1995 Aug; 96(2):1003-9. PubMed ID: 7635936
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
    Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.
    Iozzo P; Hallsten K; Oikonen V; Virtanen KA; Kemppainen J; Solin O; Ferrannini E; Knuuti J; Nuutila P
    J Clin Endocrinol Metab; 2003 May; 88(5):2055-60. PubMed ID: 12727954
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acute effects of celiprolol on muscle blood flow and insulin sensitivity: studies using [15O]-water, [18F]-fluorodeoxyglucose and positron emission tomography.
    Malminiemi K; Laine H; Knuuti MJ; Ruotsalainen U; Oikonen V; Haaparanta M; Nuutila P
    Eur J Clin Pharmacol; 1997; 52(1):19-26. PubMed ID: 9143862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
    Iozzo P; Gastaldelli A; Järvisalo MJ; Kiss J; Borra R; Buzzigoli E; Viljanen A; Naum G; Viljanen T; Oikonen V; Knuuti J; Savunen T; Salvadori PA; Ferrannini E; Nuutila P
    J Nucl Med; 2006 Jun; 47(6):1016-22. PubMed ID: 16741312
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus.
    Yokoyama I; Yonekura K; Ohtake T; Kawamura H; Matsumoto A; Inoue Y; Aoyagi T; Sugiura S; Omata M; Ohtomo K; Nagai R
    J Nucl Cardiol; 2000; 7(3):242-8. PubMed ID: 10888395
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of positron emission tomography for the assessment of skeletal muscle glucose metabolism.
    Selberg O; Müller MJ; van den Hoff J; Burchert W
    Nutrition; 2002 Apr; 18(4):323-8. PubMed ID: 11934545
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy.
    Behrens GM; Boerner AR; Weber K; van den Hoff J; Ockenga J; Brabant G; Schmidt RE
    J Clin Invest; 2002 Nov; 110(9):1319-27. PubMed ID: 12417571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.